Biotricity, Inc. (BTCY) |
|
0.79 -0.03 (-3.66%)
|
02-02 15:56 |
|
Open: |
0.7977 |
Pre. Close: |
0.82 |
|
High:
|
0.8198 |
Low:
|
0.711 |
|
Volume:
|
169,243 |
Market Cap:
|
40(M) |
|
|
|
Technical analysis |
as of: 2023-02-02 4:29:20 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 1.13 One year: 1.32 |
| Support: |
Support1: 0.61 Support2: 0.39 |
| Resistance: |
Resistance1: 0.97 Resistance2: 1.13 |
| Pivot: |
0.78  |
| Moving Average: |
MA(5): 0.81 MA(20): 0.75
MA(100): 0.88 MA(250): 1.35 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 49.8 %D(3): 53.3 |
| RSI: |
RSI(14): 53 |
| 52-week: |
High: 3.34 Low: 0.39 |
| Average Vol(K): |
3-Month: 202 (K) 10-Days: 310 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BTCY ] has closed below upper band by 47.6%. Bollinger Bands are 51.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.82 - 0.83 |
0.83 - 0.83 |
|
Low:
|
0.7 - 0.7 |
0.7 - 0.71 |
|
Close:
|
0.78 - 0.79 |
0.79 - 0.8 |
|
Company Description |
|
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California. |
Headline News |
Fri, 27 Jan 2023
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace
Thu, 26 Jan 2023
Where Will Biotricity Inc (BTCY) Stock Go Next After It Is Up 10.81% in a Week? - InvestorsObserver
Thu, 26 Jan 2023
Biotricity Inc (BTCY) Signs Distribution Agreement With Top 5 ... - StreetInsider.com
Mon, 23 Jan 2023
Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET - Yahoo Finance
Thu, 19 Jan 2023
Purpose Investments Inc. Announces January 2023 Distributions - InvestorsObserver
Mon, 28 Nov 2022
What is the Market's View on Biotricity Inc (BTCY) Stock's Price and Volume Trends Monday? - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
51 (M) |
| Shares Float |
39 (M) |
|
% Held by Insiders
|
18.4 (%) |
|
% Held by Institutions
|
4.9 (%) |
|
Shares Short
|
333 (K) |
|
Shares Short P.Month
|
330 (K) |
Stock Financials |
|
EPS
|
-0.71 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-0.21 |
|
Profit Margin (%)
|
-260.6 |
|
Operating Margin (%)
|
-218.4 |
|
Return on Assets (ttm)
|
-105.7 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
31.7 |
|
Gross Profit (p.s.)
|
0.09 |
|
Sales Per Share
|
0.16 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-18 (M) |
|
Levered Free Cash Flow
|
-10 (M) |
Stock Valuations |
|
PE Ratio
|
-1.13 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-3.96 |
|
Price to Sales
|
4.69 |
|
Price to Cash Flow
|
-2.26 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
